ArticleBreast care (Basel, Switzerland)2022

Bone Safety Profile of Steroidal Aromatase Inhibitor in Comparison to Nonsteroidal Aromatase Inhibitors in Postmenopausal Women with Breast Cancer: A Network Meta-Analysis.

Shanshan Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.